Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). The Dep
about
Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillationAntiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillationAntiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillationPharmacological cardioversion for atrial fibrillation and flutterEuropean Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm SocietyAtrial fibrillation in heart failure: an innocent bystander?Preventing sudden death and the use of prophylactic implanted defibrillatorsManagement Of Atrial Fibrillation In Patients With Heart FailureAtrial fibrillation in heart failure patients: prevalence in daily practice and effect on the severity of symptoms. Data from the ALPHA study registry.Rate Versus Rhythm Control Pharmacotherapy For Atrial Fibrillation: Where are We in 2008?Amiodarone: what have we learned from clinical trials?Pharmacological management of atrial fibrillation: an update.Atrial fibrillation in congestive heart failure.A review of the pharmacokinetics, electrophysiology and clinical efficacy of dronedarone.Special problems with antiarrhythmic drugs in the elderly: safety, tolerability, and efficacy.Heart failure complicated by atrial fibrillation: mechanistic, prognostic, and therapeutic implications.Atrial fibrillation in patients with congestive heart failure.Evolving concepts in the treatment of atrial fibrillation.Pharmacologic management of atrial fibrillation in the elderly: rate control, rhythm control, and anticoagulation.Characteristics and outcomes of patients with advanced chronic systolic heart failure receiving care at the Veterans Affairs versus other hospitals: insights from the Beta-blocker Evaluation of Survival Trial (BEST)Novel pharmacological targets for the rhythm control management of atrial fibrillation.Prevalence, prognostic significance, and treatment of atrial fibrillation in congestive heart failure with particular reference to the DIAMOND-CHF study.Atrial fibrillation in heart failure: prognostic significance and management.Ventricular rate control during atrial fibrillation and AV node modifications: past, present, and future.Can antiarrhythmic drugs save lives in patients with congestive heart failure?Analysis of the surface electrocardiogram for monitoring and predicting antiarrhythmic drug effects in atrial fibrillation.New antiarrhythmic agents for atrial fibrillation and atrial flutter.Beta-Adrenergic blockers as antiarrhythmic and antifibrillatory compounds: an overview.CRT-D therapy in patients with left ventricular dysfunction and atrial fibrillation.Modern management of arrhythmias.Antiarrhythmic drug therapy for atrial fibrillation: are the guidelines guiding clinical practice?Implication from randomized trials of rate and rhythm controls on management of patients with persistent atrial fibrillation.Evaluation of left ventricular long-axis function in cases of rheumatic pure mitral stenosis with atrial fibrillation.Management of atrial fibrillation: focus on the role of dronedarone.Amiodarone: a multifaceted antiarrhythmic drug.Atrial fibrillation and outcomes in heart failure with preserved versus reduced left ventricular ejection fractionAtrial fibrillation in patients with heart failure: Role of catheter ablation therapies.Atrial fibrillation and congestive heart failure: a two-way street.Amiodarone for atrial fibrillation following cardiac surgery: development of clinical practice guidelines at a university hospital.Clinical review: treatment of new-onset atrial fibrillation in medical intensive care patients--a clinical framework
P2860
Q24187110-C309DC44-4CCB-43DC-BDF5-F3A0153B9EC6Q24197643-78E212C3-EEF0-4B4E-8B93-2DFB8155C515Q24243067-C235059A-7D70-42C8-85EA-1C6F7D7CD9D8Q24246997-8B98673B-13FB-4E0C-8C03-856AB5A1799FQ26796261-04C0AF8E-C2F1-4F21-84E7-F1F35701CFB1Q27010588-15900CF7-D75A-4B4E-9C7C-44B58567C7C1Q28200390-4949777B-0E77-4AA7-8431-69C515B3D29DQ30354835-384149EC-6505-43D8-9865-9CBF433D2821Q31085984-2842B405-1708-4A16-BA9C-9432FFC6D781Q33585592-7230E4C2-D0BB-4A99-9A85-BD27C43F9E48Q33838684-ED8D5750-0D14-4903-A13F-6DF60C88AF0BQ33845159-C07D856A-36FC-482C-9A9C-FEE046FFC790Q33954432-8A2C1844-59EB-4AD5-A6A7-10995B13CFB1Q34612472-6D9806D8-B6A0-4FF4-834B-ABD28C7FB892Q34989738-88D83A14-C269-4C27-857B-E6B88A5E4A6FQ35155253-A5A02FAF-A732-483F-8F53-DA843A77D83EQ35197762-5F2C0CB5-A007-42C6-8307-D068EA39F63BQ35198963-6E58FE68-6BE1-4C91-9B77-AB7876DF3727Q35198970-B7FC1A3D-8663-4AF1-9FF3-092CD51F96A9Q35225793-55E2FB58-A4D9-43D2-8386-61CBB72A10FEQ35489060-237FE15F-582F-4D67-8843-34F5227723E1Q35612755-7CB57A81-69B7-4D30-A4DB-4349A972ACBAQ35684055-C1D91D1C-A031-4813-A5D2-A3E38D6258A5Q35686164-C163CCE9-E1EE-4844-887F-D74FDBC8260AQ35696418-A486A2BF-C7BF-4BCB-9F1C-658ED2F49C52Q36045458-478D2E90-1816-4CD9-BE47-E67904936CA5Q36150617-8BF1AEC5-1A92-44A7-AF49-A7F976BACB89Q36167681-5828322E-5A86-4B96-9771-B68E00BF3CAFQ36307931-D56EA346-C95A-4A8F-8E92-0845DCD7248DQ36388570-87AD2114-1C8A-41E2-B776-5130B28092D7Q36441334-28AE828C-AA47-483A-B8CE-CF8DB1BCC69AQ36456002-EFD3A378-7A4F-4D30-A49D-2050B9D67A8EQ36569724-EA772DA6-69C2-4C92-9756-AB54224E1FA5Q36581235-466C33DA-10C8-4D31-8689-1310E2E23445Q36586992-474FEF03-1FF7-49C8-BDB9-2F0BD903F878Q36701777-3F6DCBBB-7305-40E6-999E-66A7BAF73205Q36768493-272F8F11-F6D8-40B6-A859-BA9FDD7F75B7Q36830280-EB664734-9F87-4B24-9EA4-ABB5C66C02E2Q36936924-01CA19D7-0066-4094-B6AE-26A10D4BEAEDQ37013160-C5809241-425A-4E59-A792-5B9B002C8CC6
P2860
Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation: observations from the veterans affairs congestive heart failure survival trial of antiarrhythmic therapy (CHF-STAT). The Dep
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Spontaneous conversion and mai ...... ic therapy (CHF-STAT). The Dep
@en
Spontaneous conversion and mai ...... rial of antiarrhythmic therapy
@nl
type
label
Spontaneous conversion and mai ...... ic therapy (CHF-STAT). The Dep
@en
Spontaneous conversion and mai ...... rial of antiarrhythmic therapy
@nl
prefLabel
Spontaneous conversion and mai ...... ic therapy (CHF-STAT). The Dep
@en
Spontaneous conversion and mai ...... rial of antiarrhythmic therapy
@nl
P2093
P921
P1433
P1476
Spontaneous conversion and mai ...... ic therapy (CHF-STAT). The Dep
@en
P2093
P304
P356
10.1161/01.CIR.98.23.2574
P407
P577
1998-12-01T00:00:00Z